TL1 Project Title: Evaluation of Nuanced Antibody Response to C-Terminal Peptide of ApoAI in Cardiovascular Disease
Patients with cardiovascular disease (CVD) possess IgG auto-antibodies targeting apolipoprotein A-I (ApoA-I), which correlates to poor CVD outcomes. Evaluation of these antibodies have focused on the IgG response to the full length unmodified protein. My project with Dr. Venditto will evaluate a much more nuanced immune...
See MoreRelating scientific principles and concepts to the prevention of disease
